Page 6 - 2021_07-Haematologica-web

Cell Therapy & Immunotherapy
1846 Anti-RhD antibody therapy modulates human natural killer cell function Shlomo Elias et al.
https://doi.org/10.3324/haematol.2019.238097
1857 Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy Katja Klausz et al.
https://doi.org/10.3324/haematol.2020.251371
Chronic Lymphocytic Leukemia
1867 Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicenter trial
Olivier Tournilhac et al.
https://doi.org/10.3324/haematol.2019.239566
Chronic Myeloid Leukemia
1876 Fatigue in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy: predictors and the relationship with physical activity Lando Janssen et al.
https://doi.org/10.3324/haematol.2020.247767
Hematopoiesis
1883 Thrombopoietin maintains cell numbers of hematopoietic stem and progenitor cells with megakaryopoietic potential Aled O’Neill et al.
https://doi.org/10.3324/haematol.2019.241406
Hemophagocytosis
1892 A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis Qing Zhang et al.
https://doi.org/10.3324/haematol.2020.253781
Hemostasis
1902 Factor VIII activity and bleeding risk during prophylaxis for severe hemophilia A: a population pharmacokinetic model Andreas Tiede et al.
https://doi.org/10.3324/haematol.2019.241554
Myeloproliferative Disorders
1910 Crucial role of hematopoietic JAK2 V617F in the development of aortic aneurysms Tetsuro Yokokawa et al.
https://doi.org/10.3324/haematol.2020.264085
Non-Hodgkin Lymphoma
1923 Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis Martin D. Berger et al.
https://doi.org/10.3324/haematol.2020.249680
1932 Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study Adam S. Zayac et al.
https://doi.org/10.3324/haematol.2020.270876
Plasma Cell Disorders
1943 Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression
Antonio G. Solimando et al.
https://doi.org/10.3324/haematol.2019.239913
1957 Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial
Graham H. Jackson et al.
https://doi.org/10.3324/haematol.2020.247130
haematologica Journal of the Ferrata Storti Foundation
Haematologica 2021; vol. 106 no. 7 - July 2021 http://www.haematologica.org/